Certara, Inc. (CERT)
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Address
4 RADNOR CORPORATE CENTER, SUITE 350
RADNOR, PA 19087
Founded
2008
Number of Employees
1,391
Website
http://www.certara.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | $136 | $6,402 | $7,992 | $4,843 |
| Average Price | - | - | - | - | - | - | - | - | $14.06 | $22.35 | $17.91 | $19.57 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 9,663 | 286,408 | 446,268 | 247,446 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | -28.9% | -55.3% | -44.2% | -48.9% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | 31.3% | 7.4% | 25.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | -66.1% | -86.6% | -51.6% | -74.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 21% | 5% | 3% | 14% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at CERT make a trade.
Creating a free account takes less than one minute